Apollon Formularies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Stephen Barnhill
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO
Stephen Barnhill (64 yo)
3.1yrs
Tenure
Dr. Stephen D. Barnhill Jr., M. D., is Chairman and Chief Executive Officer at Apollon Formularies, Ltd. and has been its Director since April 12, 2021. He was Interim President, Chief Executive Officer at...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 3.1yrs | no data | no data | |
| Chief Science Officer | 2.3yrs | no data | no data | |
| Non-Executive Director | 2.3yrs | no data | no data | |
| Head of Advisory Board & Consultant | no data | no data | no data | |
| Non-Executive Director | 3.1yrs | no data | no data | |
| Member of Advisory Board & Consultant | no data | no data | no data |
2.7yrs
Average Tenure
56yo
Average Age
Experienced Board: APOL's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.